Skip to main content

Table 1 Demographic information of MPS III participants

From: Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)

Participant ID

Sex

Age (years)

MPS III subtype

Ethnicity

Current medication/intervention (effectivenessa)

Previous sleep intervention (effectivenessa)

MPS1

Male

2

B

Pakistani

None

None

MPS2

Male

4

A

White Polish

None

None

MPS3

Male

5

B

White British

None

Behavioural advice (parents had already tried techniques)

MPS4

Male

10

B

Pakistani

Melatoninb (good for settling)

Loperamide

Herbal medicine (no effect after first week)

MPS5

Female

10

B

Pakistani

Walking (helpful)

Risperidone (no effect)

None

MPS6

Female

11

A

White British

Gonapeptyl

None

MPS7

Male

14

A

White British

Chloral hydrate, zopiclone (short-term effects only), levetiracetam, ibuprofen, hyoscine

Melatonin (short-term effect only)

Behavioural techniques (no effect)

MPS8

Female

15

A

White British

Zopiclone, clonazepam, midazolam, sodium valproate, Senokot, Movicol, omeprazole, glycopyrrolate, morphine, paracetamol

Melatonin (no effect)

Temazepam (initial effect but discontinued due to distress/tearfulness)

  1. aEffectiveness of intervention for sleep as reported by parents
  2. bMelatonin treatment ceased 2 weeks prior to data collection